CVX-22

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameCVX-22

Drug Alias NameCVX-22

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionThrombospondin 1 agonists

TargetsThrombospondin 1

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCovX Research LLC

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCovX Research LLC

Active IndicationsN/A

Inactive IndicationsMelanoma

ATC CodeN/A